Form 8-K Ocera Therapeutics, Inc. For: Nov 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Ocera Therapeutics (OCRX) Tops Q3 EPS by 16c
November 13, 2014 4:59 PM ESTOcera Therapeutics (NASDAQ: OCRX) reported Q3 EPS of ($0.34), $0.16 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $233 thousand versus the consensus estimate of $200 thousand.
For earnings history and earnings-related data on Ocera Therapeutics (OCRX) click here.
... More